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ABSTRACT 
Compliance with data protection requirements is always a tricky business and even more 
intricate when it comes to cutting-edge technologies such as distributed ledger technology 
(DLT), better known as Block Chain Technology (BCT). These difficulties increase even 
more when the personal data concerned is accorded a special level of protection, as is the 
case with health data. The following article aims to describe and analyze the legal issues 
associated with this scenario. The focus here is on the European Union's (EU) General 
Data Protection Regulation (GDPR) 1, which took effect on May 25, 2018. Furthermore, 
the functionality of BCT and its possible fields of application in healthcare will be outlined. 
	
		
1  Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection 
of natural persons with regard to the processing of personal data and on the free movement of such data, and 
repealing Directive 95/46/EC (General Data Protection Regulation) (OJ L 119 of 4.5.2016, p. 1). 
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I. HYPE OR HOPE? 
 
Block Chain Technology (BCT) has recently been referred to as “the most disruptive tech 
in decades“.2 Others consider it a fundamental technology that “has the potential to create 
new foundations for our economic and social systems.”3 In that respect, the Gartner Hype 
Cycle, introduced in 1995 by the technology analyst firm Gartner, Inc., proposes useful 
guidance. The hype cycle model traces the evolution of technological innovations in terms 
of expectations or visibility of the value of the technology. It explains the path that tech-
nologies generally take, from their initial introduction into the market until their eventual 
maturation into useful components of broader solutions.4 According to this model, the 
five key phases of a technology’s life cycle are: 
(1) Innovation Trigger: A potential technology breakthrough kicks things off. Early 
proof-of-concept stories and media interest trigger significant publicity. Often 
no usable products exist and commercial viability is unproven. 
(2) Peak of Inflated Expectations: Early publicity produces a number of success sto-
ries – often accompanied by scores of failures. 
(3) Trough of Disillusionment: Interest wanes as experiments and implementations 
fail to deliver. Producers of the technology shake out or fail. Investments con-
tinue only if the surviving providers improve their products to the satisfaction of 
early adopters. 
(4) Slope of Enlightenment: More instances of how the technology can benefit the 
enterprise start to crystallize and become more widely understood. Second- and 
third-generation products appear from technology providers. More enterprises 
fund pilots; conservative companies remain cautious. 
(5) Plateau of Productivity: Mainstream adoption starts to take off. Criteria for as-
sessing provider viability are more clearly defined. The technology's broad mar-
ket applicability and relevance are clearly paying off. 
In a recent study based on data from more than 3,100 CIOs from 98 countries Gartner 
sees BCT as a whole at the Peak of Inflated Expectations phase, whereas blockchain in e-
health is still assigned to the phase of Innovation Trigger,5 as most initiatives are still in 
alpha or beta stage. But without any doubt BCT in e-health will rapidly ascend to the 
	
		
2  Lucas Mearian, What is blockchain? The most disruptive tech in decades, COMPUTERWORLD (May 31, 2018 
1:35 PM PT), https://www.computerworld.com/article/3191077/security/what-is-blockchain-the-most-dis-
ruptive-tech-in-decades.html?page=2 (last visited Aug. 20, 2018, 01:30 PM). 
3  MARCO IANSITI & KARIM R. LAKHANI, THE TRUTH ABOUT BLOCKCHAIN, IN HBR'S 10 MUST READS 
2018: THE DEFINITIVE MANAGEMENT IDEAS OF THE YEAR FROM HARVARD BUSINESS REVIEW 159 (2018). 
4  See for a critical analysis, Martin Steinert & Ozgur Dedehayir, The hype cycle model: A review and future 
directions, 108 TECHNOL. FORECAST. SOC. CHANGE 28 ff. (July 2016). 
5  GARTNER (ED.), BLOCKCHAIN STATUS 2018: MARKET ADOPTION REALITY (2018), quoted by: Christiane 
Pütter, Erwartungen an Blockchain zurückstutzen, CIO (June 22, 2018), https://www.cio.de/a/erwartungen-
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Peak of Inflated Expectations phase. Consequently, there is some evidence that the excite-
ment around using BCT in healthcare is growing.6 An example of this may be the some-
what evangelical fervor of some over-enthusiastic early adopters especially in the U.S., but 
also in other tech-savvy countries. Others argue that BCT in healthcare is all hype – a 
technological hammer looking for a nail – and that the complexities of health information 
could prevent its practical use.7 However, most people seem to have recognized that, 
when the dust of the hype clears, BCT may have a significant role to play as a main com-
ponent of the digital transformation of the healthcare sector. According to the Gartner 
study, this technology is upwards of only ten years from mainstream adoption. Therefore, 
it comes as no surprise that many advocates are already pointing to BCT’s potential to 
revolutionize healthcare in terms of the secure and efficient sharing of health data, of fos-
tering patient empowerment, etc.8 
Even good old Europe has jumped on the bandwagon. Within the framework of EU’s 
Horizon 2020 research and innovation program, the research project My Health My Data 
(MHMD) has been funded 3,455.190 EUR (ca. 4 mio. USD). It aims to use BCT to enable 
medical data to be stored and transmitted safely and effectively. The MHMD project is 
centered on the connection between organizations and individuals, encouraging hospitals 
to start making anonymized data available for open research, while prompting citizens to 
become the ultimate owners and controllers of their health data. For these purposes, it 




6  See, e.g., William Gordon, Adam Wright & Adam Landman, Blockchain in Health Care: Decoding the Hype, 
NEJM Catalyst (February 9, 2017), https://catalyst.nejm.org/decoding-blockchain-technology-health/ (last 
visited Sept. 17, 2018, 10:05 AM). 
7  Id. 
8  See, e.g., CHRISTINA CZESCHIK & RATKO STAMBOLIJA, A QUICK GUIDE TO BLOCKCHAIN IN 
HEALTHCARE, 18 et seq. and passim (2nd ed. 2018); PETER B. NICHOL, THE POWER OF BLOCKCHAIN FOR 
HEALTHCARE: HOW BLOCKCHAIN WILL IGNITE THE FUTURE OF HEALTHCARE, 14 et seq. (2017); AXEL 
SCHUMACHER, BLOCKCHAIN & HEALTHCARE STRATEGY GUIDE 2017: REINVENTING HEALTHCARE: TO-
WARDS A GLOBAL, BLOCKCHAIN-BASED PRECISION MEDICINE, 2 et seq. (2017); Devon S. Connor-Green, 
Blockchain in Heathcare Data, 21 INTELL. PROP. & TECH. L. J. 93, at 106-07 (2017); Leslie Mertz, (Block) Chain 
Reaction: A Blockchain Revolution Sweeps into Health Care, Offering the Possibility for a Much-Needed Data 
Solution, 9(3) IEEE PULSe 4 (2018); Juan M. Roman-Belmonte, Hortensia De la Corte-Rodriguez & E. Carlos 
Rodriguez-Merchan, How blockchain technology can change medicine, 130 POSTGRAD MED 420 (2018); Gor-
don, Wright & Landman, supra note 5; David Randall, Pradeep Goel & Ramzi Abujamra, Blockchain Appli-
cations and Use Cases in Health Information Technology, 8 J HEALTH MED INFORMAT 276 (2017); Stanislaw 
P. Stawicki, Michael S. Firstenberg & Thomas J. Papadimos, What's new in academic medicine? Blockchain 
technology in health-care: Bigger, better, fairer, faster, and leaner, 4(1) INT J ACAD MED 1 (2018); Viola Hoff-
mann, Blockchain technology as an opportunity for more transparency and self-determination, GESUND-
HEITSINDUSTRIE BW (January 15, 2018), https://www.gesundheitsindustrie-bw.de/en/article/news/block-
chain-technology-as-an-opportunity-for-more-transparency-and-self-determination/ (last visited Sept. 17, 
2018, 10:40 AM). 
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II. HOW DOES BCT WORK? 
 
BCT was the brainchild of the Bitcoin creator(s) acting under the pseudonym Satoshi 
Nakamoto. Bitcoin saw the light of day in a paper of 2008 and was conceptualized as a 
decentralized, cryptographically empowered currency framework for financial interac-
tions without an intermediary. However, while cryptocurrencies are part of the block-
chain phenomena, BCT is not limited to cryptocurrencies. Rather, BCT has the potential 
to restructure economic and social systems and even create new foundations in them. So 
far there have also been use cases for personal identity verification, land-title deeds, intel-
lectual property ownerships, public and financial records, and digital (or “smart”) con-
tracts that automatically execute when certain pre-defined conditions are met. From a 
technological point of view a smart contract means a piece of software that controls 
and/or documents or even effects a legally relevant activity. 
In general, the blockchain may be defined as a public (distributed) ledger which works 
like a log by keeping a growing list of records, called “blocks”, of all transactions in a 
chronological order, secured by an appropriate consensus mechanism and providing a rec-
ord that is, at least in principle,10 immutable. BCT is also often considered as a decentral-
ized database using the peer-to-peer principle. As opposed to a traditional (e.g., relational) 
database, there is no central ownership. Instead, information is managed through the con-
sensus of the network members, who cooperate to decide what gets added to the database. 
In sum, the exceptional characteristics of BCT include immutability, irreversibility, de-
centralization, persistence and anonymity.11  
 
The three main components of BCT are:  
(1) A peer-to-peer computer network, 
(2) a network protocol, and 
(3) a consensus mechanism.12 
Basically, the peer-to-peer network can be public (unpermissioned, open) or private (per-
missioned13, closed). The main differences between these two types are as follows: 
	
		
10  Cf., e.g., Gideon Greenspan, The Blockchain Immutability Myth, MULTICHAIN (May 4, 2017), 
https://www.multichain.com/blog/2017/05/blockchain-immutability-myth/ (last visited Sept. 17, 2018, 10:40 
AM). 
11  Cf., e.g., Dylan Yaga, Peter Mell, Nik Roby & Karen Scarfone, Draft Nistir 8202: Blockchain Technology Over-
view, NIST (January 2018), https://csrc.nist.gov/CSRC/media/Publications/nistir/8202/draft/docu-
ments/nistir8202-draft.pdf (last visited Sept. 17, 2018, 10:40 AM); ARSHDEEP BAHGA & VIJAY MADISETTI, 
BLOCKCHAIN APPLICATIONS. A HANDS-ON APPROACH, 20-23 (2017); Deepak Puthal, Nisha Malik, Saraju 
P. Mohanty, Elias Kougianos, & Gautam Das, Everything you Wanted to Know about the Blockchain, 7(4) 
IEEE CONSUMER ELECTRONICS MAGAZINE 6 (2018). 
12  CZESCHIK & STAMBOLIJA, supra note 8, at 10 et seq. 
13  Furthermore, permissioned blockchains which allow anyone to join a network once identity and role are de-
fined have to be differentiated from private blockchains, which allow only known or internal nodes to partic-
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(1) Control over the network. Public chains are controlled by the wide community 
of core developers, users, and miners or validators. In turn, private blockchains 
are governed out by a specific group of people or institutions.  
(2) Consensus mechanism (see below).  
(3) Application. While public chains are mostly used for payments (as seen in 
Bitcoin) or as a platform for decentralized applications’ development (as seen in 
Ethereum), almost all private chains are used for solving specific business tasks.14 
Accordingly, most healthcare BCT projects are based on private blockchains.15 
Each computer in a specific network is called a “node”. If everything is running per pro-
tocol, each node should have a copy of the entire ledger, which is sort of a local database. 
This means if one node disconnects or goes down, no data is lost and the ledger’s con-
sistency will be kept.  
The underlying principle of any transaction is that of public/private key encryption in 
order to generate digital signatures. A user has two keys: a public key to encrypt data and 
a private key to decrypt them. Each block contains a cryptographic hash of the previous 
block, a timestamp, and transaction data (generally represented as a merkle tree root 
hash). And unless one of the parties to the transaction decides to link a public key to a 
known identity it is impossible to match transactions to individuals or organizations. Alt-
hough anyone can see all the transactions on the blockchain no personal information is 
linked to them or made public. This allows any party to validate the integrity of the trans-
action ledger without violating the privacy of the parties involved in the transaction. 
All transactions are verified by a consensus mechanism which is a set of rules utilized by 
the network to verify each transaction and confirm the current state of the blockchain. In 
most cases, public chains use Proof-of-Work (PoW) systems, in which so-called “miners” 
solve cryptographic puzzles to “mine” a block in order to add to the blockchain. This pro-
cess requires an immense amount of energy and computational usage. When a miner 
solves the puzzle, they present their block to the network for verification. Verifying 
whether the block belongs to the chain or not is an extremely simple process. In contrast, 
private blockchains mostly use well-known and established consensus algorithms with 
authentified participants such as modified Proof-of-Authority (PoA). In PoA-based net-
works, transactions and blocks are validated by approved accounts, known as validators, 
who replace miners. However, as there is no “perfect” consensus mechanism, the search 
for a truly decentralized consensus mechanism is still going on.16 
In sum, the result of BCT is an expansive and distributed source of truth built not from 
trust, but through cryptographically enforced consensus. As its most important attribute 
can be considered its immutability: once something has been added to the blockchain, it 
	
		
14  See, e.g., Ivan Grekov, Is the Right to Be Forgotten a Real Problem for Blockchain?, LAWLESS.TECH (Apr. 16, 
2018), https://lawless.tech/is-the-right-to-be-forgotten-a-real-problem-for-blockchain/ (last visited Sept. 17, 
2018, 10:20 AM). 
15  CZESCHIK & STAMBOLIJA, supra note 8, at 10. 
16  CZESCHIK & STAMBOLIJA, supra note 8, at 11; see also, e.g., Basic Primer: Blockchain Consensus Protocol, 




COMPLIANCE  ELLIANCE  JOURNAL   |    VOLUME 4   NUMBER 2   2018 
ULRICH M. GASSNER   |   BLOCKCHAIN IN EU E-HEALTH – BLOCKED BY THE BARRIER OF DATA PROTECTION? 
 
PAGE  9 
is permanently stored in a large number of computers.17 
III. HOW CAN BCT BE APPLIED TO HEALTHCARE? 
 
Realized and probable applications of BCT in healthcare can be divided into eight main 
areas, namely electronic health records (EHR) management and interoperability, biomed-
ical research, medication planning and management, revenue cycle management (RCM), 
procurement policies and supply chain management (SCM), internet of medical things 
(IoMT), health professions education, and international medicine and global health. 
 
A. EHR management and interoperability 
 
Most healthcare systems suffer from the siloing of patients’ health data and a lack of in-
teroperability between different domains. Several current health record systems – in the 
U.S., for example, as well as in most European countries with the exception of Estonia18 
– are composed of an enormous number of disconnected databases. Health records are 
usually spread across various institutions, health care providers, and suppliers that often 
use incompatible databases, without full access to a shared patient database. This lack of 
interoperability leads to enormous inefficiencies.19 
BCT would provide the ability to replace these disparate systems with an integrated sys-
tem that, with the use of smart contracts and fully auditable history, enables peer-to-peer 
interoperability among participants (such as physicians, medical institutions, insurance 
companies, and pharmacies) within transactions.20 Using BCT as a data management tool 
would be especially useful for the implementation of so-called integrated healthcare mod-
els, in which the stationary and ambulatory sectors need to exchange information to create 
an efficient and agreeable patient journey.21 Instant access to an agreed set of data about a 
patient would also mean better data for better care in acute, life-threatening situations 
	
		
17  WRIGHT & LANDMAN, supra note 6. 
18  This small EU member state was the first country to implement a blockchain into their electronic healthcare 
record (EHR) system with the collaboration of a local company named Guardtime, using keyless signature 
infrastructure (KSI), Danielle Siarri, The potential of blockchain in HER, Oct. 6, 2017, 
https://www.himss.eu/himss-blog/potential-blockchain-ehr [last visited Oct. 18, 2018, 10:40 AM]; Johnathon 
Marshall, Estonia prescribes blockchain for healthcare data security, PWC (March 16, 2017), 
http://pwc.blogs.com/health_matters/2017/03/estonia-prescribes-blockchain-for-healthcare-data-secu-
rity.html (last visited Sept. 17, 2018, 10:10 AM); see also the official website https://e-estonia.com/blockchain-
healthcare-estonian-experience/. 
19  CZESCHIK & STAMBOLIJA, supra note 8, at 18. 
20  Randall, Goel & Abujamra, supra note 8; Igor Radanović & Robert Likić; Opportunities for Use of Blockchain 
Technology in Medicine, APPL HEALTH ECON HEALTH POLICY (July 18, 2018), doi: 10.1007/s40258-018-0412-
8; Arlindo Flavio da Conceição, Flavio Soares Correa da Silva, Vladimir Rocha, Angela Locoro & João Marcos 
Barguil, Electronic Health Records using Blockchain Technology, CORNELL UNIVERSITY LIBRARY (April 26, 
2018, https://arxiv.org/abs/1804.10078 (last visited Sept. 17, 2018, 10:10 AM). 
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and for better treatment of chronic longer-term conditions (e.g., diabetes22). Patients 
could be treated more quickly and in a more targeted way. As a result, for example, the 
duplication of examinations or treatments would be prevented, ultimately increasing ef-
ficiency.23 Furthermore, sharing the ledger among the participants would bring transpar-
ency to the whole process of treatment, from monitoring drug compliance to facilitating 
cost controls.24 In addition to offering interoperability, blockchain transactions would 
also have the advantage of being cryptographical and irrevocable, thus ensuring privacy 
across parties25 and reducing fraud.26 Moreover, in the BCT environment, the patient (or 
his relatives) would be able to designate by whom the data can be accessed (and at what 
level of access) by the use of keys that only users would be able to dispose of (either private 
or public).  
The key management and the access control could be encoded in a chaincode, thus ensur-
ing patients’ autonomy and self-determination.27 
 
B. Biomedical research 
 
Lack of reproducibility, related to a wide range of scientific misconduct aspects, from er-
rors to frauds, compromises the outcomes of clinical studies and undermines research 
quality. BCT offers the chance to tackle this huge medical challenge for contemporary 
biomedical research. Study data would be time stamped and publicly more transparent 
than now. All plans, consents, protocols, and outcomes could be stored in a blockchain. 
Furthermore, smart contracts could be used to link together several phases of a clinical 
study.28 Additionally, as a more general factor, the application of BCT could bring about 
the access to a large pool of anonymous and encrypted medical data that could be used 





22  Simon Lebech Cichosz, Mads Nibe Stausholm, Thomas Kronborg, Peter Vestergaard & Ole Hejlesen, How to 
Use Blockchain for Diabetes Health Care Data and Access Management: An Operational Concept, J DIABETES 
SCI TECHNOL (July 26, 2018), doi: 10.1177/1932296818790281. 
23  Hoffmann, supra note 8. 
24  Alevtina Dubovitskaya, Zhigang Xu, Samuel Ryu, Michael Schumacher & Fusheng Wang, How Blockchain 
Could Empower eHealth: An Application for Radiation Oncology, in: Data Management and Analytics for 
Medicine and Healthcare 3, 4-5 (Edmon Begoli, Fusheng Wang & Gang Luo eds. 2017). 
25  CZESCHIK & STAMBOLIJA, supra note 8, at 35; Randall, Goel & Abujamra, supra note 8. 
26  Randall, Goel & Abujamra, supra note 8. 
27  CZESCHIK & STAMBOLIJA, supra note 8, at 35-36; Dubovitskaya, Xu, Ryu, Schumacher & Wang, supra note 
24, at 5; Radanović & Likić, supra note 20; Randall, Goel & Abujamra, supra note 8; Hoffmann, supra note 
8. 
28  Mehdi Benchoufi & Philippe Ravaud, Blockchain technology for improving clinical research quality, 18 TRI-
ALS 335 (2017); Dubovitskaya, Xu, Ryu, Schumacher & Wang, supra note 24, at 5; Radanović & Likić, supra 
note 20. 
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C. Medication planning and management 
 
Without any doubt, medication reconciliation is one of the most important tasks related 
to quality of care and patient safety. Using appropriate patient safety algorithms via BCT, 
medication errors, contraindications, and medication prescriptions could be reconciled 
near-instantaneously - without the need for time-consuming medication reconciliation 
processes.30 
 
D. Revenue cycle management (RCM) 
 
BCT can help hospitals and health systems to improve the performance of revenue cycle 
management by reducing denials and boosting patient collections because it allows pay-
ers, providers, and financial institutions to share information via private distributed ledg-
ers.31 
 
E. Procurement policies and supply chain management (SCM)  
 
BCT could considerably improve procurement policies since it would ensure that the sup-
ply of goods is transparent, verifiable, and more efficient. Suppliers could be more easily 
controlled and, if necessary, held accountable for the quality of their products. The logis-
tics of pharmaceutical and medical device manufacturers could profit from BCT espe-
cially as there is a high risk of substandard or counterfeited products entering the supply 
chain. By introducing smart contracts, checks and transactions could be carried out auto-
matically. In transactions, in which no conflicts are detected, even payments might be au-
tomatized.32 
 
F. Internet of medical things (IoMT) 
 
IoMT refers to the collection of medical devices and applications that connect to 
healthcare IT systems through online computer networks. Medical devices equipped with 
WiFi, Bluetooth, or other interfaces allow the machine-to-machine communication that 
is the basis of IoMT. The cybersecurity of the connected medical devices and the vulner-
able sensitive data that passes through the IoMT could be ensured by BCT.33 
	
		
30  CZESCHIK & STAMBOLIJA, supra note 8, at 20 et seq.; Stawicki, Firstenberg & Papadimos, supra note 8. 
31  Kelly Gooch, 4 ways to improve RCM with blockchain, Becker’s Hospital CFO Report (March 28, 2018), 
https://www.beckershospitalreview.com/finance/4-ways-to-improve-rcm-with-blockchain.html (last visited 
Sept. 17, 2018, 10:10 AM). 
32  CZESCHIK & STAMBOLIJA, supra note 8, at 23; Stawicki, Firstenberg & Papadimos, supra note 8. 
33  CZESCHIK & STAMBOLIJA, supra note 8, at 23-4; Bernard Marr, Blockchain And The Internet Of Things: 4 
Important Benefits Of Combining These, Forbes (Jan 28, 2018, 12:28 AM), https://www.forbes.com/sites/ber-
nardmarr/2018/01/28/blockchain-and-the-internet-of-things-4-important-benefits-of-combining-these-two-
mega-trends/#50249c9a19e7 (last visited Sept. 17, 2018, 10:10 AM); Matthew Warner, Two Mega Trends Block-
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G. Health professions education 
 
Novel methods of health professions education have often been criticized for their lack of 
the ability to ascertain the origin, validity, and accountability of the knowledge that is 
created, shared, and acquired. If based on BCT it will potentially allow improved tracking 
of content and the individuals who create it, quantify educational impact on multiple 
generations of learners, and build a relative value of educational interventions.34  
Additionally, records on this digital ledger could continue to grow during the professional 
life of the physician, archiving attended conferences, written articles, and rates of success-
ful treatments.35 
 
H. International medicine and global health 
 
In the area of academic international medicine and global health, blockchain-enabled as-
sessment systems could lead to an alignment of effort allocation between settings (e.g. 
national and international), the immediate provision of much-needed assistance to low-
resource environments, and the reduction of brain-drain that plagues areas in greatest 
need for healthcare delivery. In terms of its potential impact on the current global 
healthcare system, BCT could be one of the key components of ensuring both stability 
and sustainability in the future.36 
IV. BCT VS. DATA PROTECTION? 
 
A. Patient empowerment by BCT and privacy rules? 
 
As of now, health information is widely controlled by insurance companies and funds, 
hospitals, doctors, and other intermediaries who, while claiming trustworthiness, are in a 
position to exploit that trust within essentially asymmetric power structures. BCT could 
reduce the role of these intermediaries, thus shifting the power balance in favor of the 
patients. It is capable of putting patients at the center of their health data and enabling 
data transactions not only to be secure, but also accessible and under the control of the 
individual patient. If implementing BCT can successfully re-distribute the control of 




(last visited Sept. 17, 2018, 10:10 AM). 
34  Eric Funk, Jeff Riddell, Felix Ankel & Daniel Cabrera, Blockchain Technology: A Data Framework to Improve 
Validity, Trust, and Accountability of Information Exchange in Health Professions Education, Acad Med. 
(June 12, 2018), doi: 10.1097/ACM.0000000000002326; Radanović & Likić, supra note 20. 
35  Radanović & Likić, supra note 20. 
36  Stawicki, Firstenberg & Papadimos, supra note 8. 
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However, BCT cannot solve all trust and privacy concerns surrounding health data pro-
tection. Therefore, it has been proposed that the U.S. federal regulation governing 
healthcare data privacy, the Health Insurance Portability and Accountability Act of 1996 
(HIPAA),38 should be supplemented with stricter rules in line with the model of the 
GDPR39. Coupled with BCT, it would affirm a paradigm shift in the US-American legal 
landscape in terms of data ownership.40 The GDPR, however, does not explicitly refer to 
the intrinsically problematic concept of personal data ownership. Rather, it follows 
merely from the wording of sentence 2 of its Recital41 7, ”Natural persons should have 
control of their own personal data”, that data subjects should be in control of their per-
sonal data. 
The regulation paints the term “personal data” with a very broad stroke. It is defined in 
Article 4(1) GDPR as “any information relating to an identified or identifiable natural 
person (‘data subject’); an identifiable natural person is one who can be identified, directly 
or indirectly, in particular by reference to an identifier such as a name, an identification 
number, location data, an online identifier, or to one or more factors specific to the phys-
ical, physiological, genetic, mental, economic, cultural, or social identity of that natural 
person”. It is well established that personal data that has been encrypted or hashed still 
qualifies as personal data within this definition as it is merely pseudonymized and not 
irreversibly anonymized.42 It follows that not only personal data but also public keys used 
in BCT qualify as personal data, just like data relating to a natural person that is hashed 
to the chain.43 As a consequence, cryptographically modified health data stored, e.g., on a 
distributed ledger of an integrated EHR, in addition to public keys, are subject to the 
GDPR. 
Furthermore, as opposed to the narrower approach of the HIPAA Privacy Rule44 all in-
dividuals, organizations, and companies that are either “controllers”45 or “processors”46 
	
		
38  HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996, Pub. L. No. 104-191, 110 Stat. 1936 
(1996). 
39  Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection 
of natural persons with regard to the processing of personal data and on the free movement of such data, and 
repealing Directive 95/46/EC (General Data Protection Regulation) (OJ L 119 of 4.5.2016, p. 1). 
40  Connor-Green, supra note 8, at 99. 
41  Recitals are important because they are used by the Court of Justice of the European Union (CJEU) and other 
EU institutions in order to interpret any Directive or Regulation. 
42  MICHÈLE FINCK, BLOCKCHAINS AND DATA PROTECTION IN THE EUROPEAN UNION 10-11, SSRN (2017), 
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3080322 (last visited Sept. 17, 2018, 4:20 PM); cf. fur-
ther Article 29 Working Party, Opinion 04/2014 on Anonymisation Techniques, 0829/14/EN, 20; but see 
BLOCKCHAIN BUNDESVERBAND, BLOCKCHAIN, DATA PROTECTION, AND THE GDPR 4 (2018). 
43  FINCK, supra note 42, at 12-14. 
44  See, e.g., Connor-Green, supra note 8, at 104-05. 
45  A “data controller” is a party that determines the purposes and means of the processing of personal data, see 
Article 4(7) of the GDPR. 
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of personal data are covered by the GDPR. This does not mean that the regulation applies 
to all processing of personal data of EU citizens or residents, as often incorrectly stated. 
Rather, pursuant to Recital 80 of the GDPR, its territorial scope includes the processing 
of personal data of someone “in the Union” by data controllers or processors outside, 
“where the processing activities are related to the offering of goods or services” to that 
person, even if they do not require payment. According to Recital 23 of the GDPR, the 
appropriate test is based on whether the organization “envisages” offering goods and ser-
vices, not on whether it does in fact offer, supply, or simply obtain personal data.47 
The goal of effective control by data subjects is accomplished by, inter alia, requiring ex-
plicit and informed consent for the collection and use of data (Articles 6(1)(1)(a) and 7 
GDPR) and imposing stiff fines on data controllers or processors for non-compliance 
(Article 83 of the GDPR). One of the cores of the regulation is formed by eight funda-
mental and dispositive rights of the data subjects that are outlined below.  
(1) The right to be informed (Articles 13 and14 of the GDPR): A data subject has the 
right to know how his or her data will be collected, processed, and stored, and for 
what purposes. 
(2) The right to access information (Article 15 of the GDPR): A data subject has the 
right to know how his or her data has been collected, processed, and stored, what 
data exists, and for what purposes. 
(3) The right to rectification (Article 16 of the GDPR): A data subject has the right 
to have inaccurate or incomplete data corrected.  
(4) The right to erasure (“the right to be forgotten”) (Articles 17 and 19 of the 
GDPR): A data subject has the right to have personal data permanently deleted 
without the need for a specific reason as to why he or she wishes to discontinue 
the data storage.  
(5) The right to restriction of processing (Article 18 of the GDPR): A data subject 
has the right to block or suppress his or her personal data being processed or used. 
(6) The right to data portability (Article 20 of the GDPR): A data subject has the 
right to transfer personal data from one data controller to another in a safe and 
secure way and in a commonly used and machine-readable format. 
(7) The right to object to processing of personal data (Article 21 of the GDPR): A 
data subject has the right to object to being subject to public authorities or com-
panies processing their data without explicit consent and to stop his or her per-
sonal data from being included in direct marketing databases. 
(8) The right to not be subject to automated decision-making (Article 22 of the 
GDPR): A data subject has the right to demand human intervention, rather than 
having important decisions made solely by algorithm. 
So, at first sight, there may be a case for supplementing the HIPAA by selected features 
	
		
47  See, e.g., Pascal Schumacher, Territorial cope of application of the GDPR – Change from the principle of terri-
toriality to effects doctrine, in New European General Data Protection Regulation. A Practitioner’s Guide 38-
39 (Daniel Rücker & Tobias Kugler eds., 2018); PAUL VOIGT & AXEL VON DEM BUSSCHE, THE EU GENERAL 
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of the GDPR in order to improve health data privacy. But when looking at some of the 
data subject’s rights mentioned above, the question may arise whether a decision has to 
be made between using BCT and applying GDPR-standards. For example, the right of 
erasure appears to be particularly at odds with the immutable nature that is at the core of 
BCT.48 Consequently, the issue whether BCT and GDPR can co-exist, is to be examined 
in more detail below. 
 
B. Does the GDPR block BCT? 
 
1. Systemic tension 
 
Arguably, BCT and the GDPR are profoundly incompatible even at a conceptual level as 
the data protection mechanisms developed for centralized data silos cannot be easily rec-
onciled with a decentralized method of data storage and protection. However, personal 
data in a blockchain system that is encrypted or hashed is still subject to the GDPR and 
public keys used in BCT surroundings are qualified as personal data under EU law.49 
Herefrom results not only a risk that the GDPR renders the operation of blockchains 
unlawful. Rather, this tension reveals also a clash between the goals of the protection of 
privacy on the one hand, and the promotion of innovative technology on the other 
hand.50 However, due to the different construction of unpermissioned and permissioned 
blockchains, the latter being dominant in healthcare, it is obvious that the latter cause 
minor difficulties from the point of view of data protection. In addition, technical solu-
tions that can contribute to BCT's data protection compliance are feasible or have already 
been implemented. This is often overlooked in the sometimes quite simplistic public dis-
cussion.51 We will turn to these issues below. 
 
2. Personal data 
 
While BCT allows for personal data to be stored in the same way as in a database, personal 
can also be stored "off chain" in a separate database and only linked to the blockchain via 
private and public cryptographic keys. Consequently, GDPR compliance can be ensured 
	
		
48  See, e.g., Samuel Martinet, GDPR and Blockchain: Is the New EU Data Protection Regulation a Threat or an 
Incentive?, Cointelegraph (May 27, 2018), https://cointelegraph.com/news/gdpr-and-blockchain-is-the-new-
eu-data-protection-regulation-a-threat-or-an-incentive (last visited Sept. 17, 2018, 10:10 AM). 
49  See supra section IV. 
50  Cf. FINCK, supra note 42, at 1-2, 28-29; cf. also Anne Toth, Will GDPR block Blockchain?, World Economic 
Forum (May 24, 2018), https://www.weforum.org/agenda/2018/05/will-gdpr-block-blockchain/ (last visited 
Sept. 17, 2018, 10:10 AM). 
51  See, e.g., Gyula Pal, The GDPR blockchain blind-spot: Regulating data and everything else, IBM (Jun 26, 2018), 
https://www.ibm.com/blogs/blockchain/2018/06/the-gdpr-blockchain-blind-spot-regulating-data-and-eve-
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in that respect.52 This would be the case, for example, if the EHR themselves continue to 
be stored in hospital databases, i.e., off the chain. However, such a workaround has the 
disadvantage that the benefits of transparency and data control with BCT are reduced. 
Thus, paradoxically, in this context the application of the GDPR leads to a result that is 
at odds is with its explicit goal that “natural persons should have control of their own 
personal data” (Recital 7).53 
Unlike transactional data, public keys cannot be moved off-chain as they are quintessen-
tial components of the BCT. Different promising work-arounds have been developed re-
cently, but it is difficult to say at this stage whether any of these techniques will be con-
sidered capable of anonymizing public keys for GDPR purposes.54 
 
3. Legal status of participants 
 
As the GDPR was designed in a pre-BCT-world with a clear division of responsibilities 
between controllers and processors, the legal status of the different participants in block-
chain networks is rather ambiguous. Especially public blockchains do not fit cleanly in 
this model. Namely, nodes cannot be considered data controllers in such a setting as they 
do not determine the means and purposes of the processing of personal data sent to the 
network by a third party.55 When it comes to private blockchains, however, it might still 
be possible to identify a central intermediary. A governance body may be established to 
oversee the permissioned network. This governance body could not only function as a 
data processor if it has influence over the purpose and means of processing within the 
meaning of Article 4(7) of the GDPR but also as a data controller who collects personal 
data from individuals serving as a single point of legal contact with the network.56 
 
 
4. Data minimization 
 
An important principle in the GDPR is data minimization. Article 5(1)(c) of the GDPR 
requires that personal data shall be “adequate, relevant and limited to what is necessary in 
relation to the purposes for which they are processed”. This principle is profoundly at 
	
		
52  Cf. FINCK, supra note 42, at 11-12; BLOCKCHAIN BUNDESVERBAND, supra note 42, at 4; Andries Van Hum-
beeck, The Blockchain-GDPR Paradox, TheLedger (Nov. 21, 2017), https://me-
dium.com/wearetheledger/the-blockchain-gdpr-paradox-fc51e663d047 (last visited Sept. 18, 2018, 01:15 AM); 
Lucas Mearian, Will blockchain run afoul of GDPR? (Yes and no), Computerworld (May 7, 2018 3:02 AM 
PT), https://www.computerworld.com/article/3269750/blockchain/will-blockchain-run-afoul-of-gdpr-yes-
and-no.html (last visited Sept. 17, 2018, 10:15 AM); Luke Sayer, Comment: Can GDPR and blockchain co-exist?, 
International Investment (May 4, 2018), http://www.internationalinvestment.net/comment/comment-can-
gdpr-and-blockchain-co-exist/ (last visited Sept. 18, 2018, 01:15 AM). 
53  Cf. Van Humbeeck, supra note 52. 
54  FINCK, supra note 42, at 14-16. 
55  FINCK, supra note 42, at 16-17; BLOCKCHAIN BUNDESVERBAND, supra note 42, at 5-6. 
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odds with data storage in a blockchain since distributed ledgers are by definition ever-
growing creatures accumulating further data with each additional block.57 
 
5. The right to rectification 
 
Data subjects’ rights under Article 16 of the GDPR imply that a rectification request can 
be addressed to any or all nodes. Two technical hurdles arise in this context. First, even in 
a permissioned blockchain – standard in healthcare environments – the data subject will 
face difficulties to identify any or all of the owners of the nodes. Second, even if the data 
subject succeeds in submitting a claim under Article 16 GDPR, they are simply unable to 
change any of the encrypted data stored in blocks due to their immutable nature. Again, 
an off-chain solution may operate as a legal loophole in that respect.58 
 
6. The right to access information 
 
With respect to Article 15 of the GDPR similar practical difficulties arise. Controllers do 
not know what personal data is stored on the blockchains, since they normally handle 
only the encrypted or hashed version. Even if a data subject were successful in contacting 
the owner of a node, the latter would not be able to verify whether the personal data of a 
data subject has been processed. Off-chain storage can again facilitate GDPR compliance 
in relation to transactional data but not public keys.59 This is all the more true when a 
governance body is established to oversee the permissioned network. 
 
7. The right to erasure 
 
According to Jan Philipp Albrecht, the former member of the European Parliament who 
shepherded the GDPR through the legislative process, the administratively easy exercise 
of the right to be forgotten “is where blockchain applications will run into problems and 
will probably not be GDPR compliant."60 It is however common ground that the right 
to be forgotten cannot be straightforwardly applied to BCT, as immutability is one of the 
essential features of blockchains.61 However, the insight has grown that there is no such 
thing as perfect immutability in blockchains. For instance, it is easy to undermine if all 
the participants in a chain decide to do so together.62 
	
		
57  FINCK, supra note 42, at 20-21. 
58  Cf. id. at 21-22. 
59  Id. at 23 (relating to public blockchains). 
60  Quoted in David Meyer, Blockchain technology is on a collision course with EU privacy law, The Privacy Advi-
sor (Feb. 27, 2018), https://iapp.org/news/a/blockchain-technology-is-on-a-collision-course-with-eu-privacy-
law/ (last visited Sept. 17, 2018, 01:20 AM). 
61  FINCK, supra note 42, at 23-24; Grekov, supra note 14. 
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Furthermore, the principle of immutability can be circumvented by an off-chain or simi-
lar solutions. Personal data which is recorded in a referenced encrypted and modifiable 
database as opposed to the blockchain itself, may be deleted in line with Article 17 of the 
GDPR.63 
With respect to public keys, GDPR compliance is again more difficult to reach. Whether 
any of the several solutions that have been developed up to now can satisfy GDPR re-
quirements remains to be seen.64 Notwithstanding that, it seems to be worth mentioning 
that certain implementing acts of the EU member states have already directed themselves 
towards a softer version of the right to erasure. For instance, Section 35(1) of the German 
Federal Data Protection Act65 provides that the data subject shall not have the right to 
erasure and the controller shall not be obligated to erase personal data if the “erasure 
would be impossible or would involve a disproportionate effort due to the specific mode 
of storage and if the data subject’s interest in erasure can be regarded as minimal”.66 
 
C. Does BCT support the GDPR 
 
Despite the tension between technology and law outlined above, it comes not totally as a 
surprise that BCT is being increasingly considered as a mechanism to help control the use 
of personal data under the GDPR.67 The reason is that both initiatives are aligned on the 
principles of secured and self-sovereign data.68 A prominent example of this coincidence 
are the guiding principles of data protection by design and data protection by default. 
Article 25(1) of the GDPR requires data protection to be designed into the development 
of business processes for products and services. Specifically, the controller should have 
technical, procedural, and organizational measures - such as pseudonymization and en-
cryption - in place in order to meet the requirements of the GDPR. Being based on ad-
vanced encryption technologies, BCT can support the implementation of GDPR-com-





63  FINCK, supra note 42, at 24; CINDY COMPERT, MAURIZIO LUINETTI, & BERTRAND PORTIER , BLOCK-
CHAIN AND GDPR, IBM WHITE PAPER, 3, (2018), https://public.dhe.ibm.com/com-
mon/ssi/ecm/61/en/61014461usen/security-ibm-security-solutions-wg-white-paper-external-61014461usen-
20180319.pdf (last visited Sept. 17, 2018, 01:20 AM). 
64  FINCK, supra note 42, at 24; but see Grekov, supra note 14. 
65  Federal Law Gazette I p. 2097. 
66  Cf. FINCK, supra note 42, at 26; BLOCKCHAIN BUNDESVERBAND, supra note 42, at 8. 
67  Cf., e.g., COMPERT, LUINETTI, & PORTIER, supra note 63; Mearian, supra note 52. 
68  COMPERT, LUINETTI, & PORTIER, supra note 63, at 2. 
69  FINCK, supra note 42, at 26, 30-31; COMPERT, LUINETTI, & PORTIER, supra note 63, at 6-7 (hinting at the 
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V. CONCLUSION AND OUTLOOK 
 
In sum, BCT offers many benefits to patients, health care service providers, hospitals, 
medical researchers, caregivers, and other healthcare parties. It integrates the healthcare 
ecosystem by adding accountability and transparency, while preserving privacy and con-
fidentiality.70 This indicates at least partial concordance with the objectives of the GDPR. 
Thus, BCT can provide an alternative means of achieving the objectives of the GDPR.71 
Yet it is also equally true that there is a systemic tension between technology and privacy 
law. And without any doubt, some blockchains in healthcare, as currently designed,72 are 
incompatible with the GDPR. 
Considering that the GDPR was developed without taking BCT into account, it could at 
first glance be wise to amend it for blockchains.73 Such a revision of the GDPR would 
acknowledge the fact that BCT creates order without law and implements private regula-
tory frameworks (lex cryptographia).74 However, for the time being, there are hardly any 
signs of EU reform initiatives in that respect. The European Parliament’s Committee on 
Industry, Research and Energy (ITRE) passed a resolution outlining the benefits of 
adopting DLT on May 16, 2018, without explicitly requiring amendments to the 
GDPR.75 The ITRE only emphasized that “it is of outmost importance [for] the DLT 
uses to be compliant with the EU legislation on data protection” and calls on the Euro-
pean Commission and the European Data Protection Supervisor (EDPS) to provide for 
further guidance on this point. After all, one seems to have recognized the problem that 
there may be some risk that the EU closes itself off from the future of the internet with 
respect to BCT. The EU Blockchain Observatory and Forum that has been launched by 
the Commission with the purpose of mapping key initiatives, monitoring developments, 
and inspiring common actions held a workshop on June 8, 2018 to examine the clashes 
and correlations between BCT and GDPR, and to provide, as far as possible, some guid-
ance to technologists, lawyers, entrepreneurs, and citizens in that respect, thus echoing 
the ITRE’s resolution on DLT and BCT. The workshop discussed separately the topics 
of technical, governance, and legal solutions and came to the positive result that there are 
only a few questions left unanswered or on which no agreement could be reached. This 
indicates that the reform of the GDPR is not the silver bullet, especially since the mills of 
	
		
70  Cf., e.g., CZESCHIK & STAMBOLIJA, supra note 8, at 34-38. 
71  FINCK, supra note 42, at 29. 
72  See for examples and use cases of BCT in the healthcare system CZESCHIK & STAMBOLIJA, supra note 8, at 25-
31; NICHOL, supra note 8, at 115-47. 
73  Toth, supra note 50. 
74  PRIMAVERA DE FILIPPI & AARON WRIGHT, BLOCKCHAIN AND THE LAW: THE RULE OF CODE, 5 and pas-
sim (2018). 
75  European Parliament Committee on Industry, Research and Energy (ITRE), Motion for a resolution on dis-
tributed ledger technologies and blockchains: building trust with disintermediation, ITRE/8/10 - 
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Brussels grind slowly. Rather, it seems to be the order of the day that regulators and offi-
cials and BCT parties and developers cooperate towards mutually acceptable solutions 
such as off-chain storage of personal data and technical work-arounds. Furthermore, the 
creation of a code of conduct for BCT in accordance with Article 40 of the GDPR might 
be useful.76 
Of course, the message that GDPR and BCT can co-exist holds also true for healthcare 
settings. Consequently, the question may arise what EU initiatives exist specifically for 
the health sector. The ITRE resolution notes that DLT allows citizens to control and have 
transparency on their health data, chose which of those data to share, including their use 
with insurance companies and the wider healthcare ecosystem, but stresses also the neces-
sity to protect the privacy of the sensitive health data.77 According to the European Com-
mission’s communication on “Enabling the digital transformation of health and care in 
the Digital Single Market; empowering citizens and building a healthier society”, pub-
lished on April 24, 2018, it is intended to monitor the implementation of the GDPR and 
the eIDAS Regulation78 with regard to health and to take account of emerging technolo-
gies such as blockchain in the context of cybersecurity.79 That makes sense, as in a decen-
tralized BCT ransomware attacks on hospitals etc. would become more difficult.80 Fur-
thermore, the Staff Working Document accompanying the Commission's communica-
tion expresses the expectation that new emerging cybersecurity solutions building on 
trusted DLT for protecting the access to personal health data such as BCT could play an 
essential role if implemented systematically across Europe as part of the national and EU 
level data and computation infrastructures for personalized medicine.81 However, this is 
insufficient in the light of the unsettled legal issues discussed above. Therefore, it remains 
to be hoped that the Commission, in its announced recommendation on the technical 
specifications for an EHR exchange format,82 will take the opportunity to clarify the ten-





76  BLOCKCHAIN BUNDESVERBAND, supra note 42, at 9. 
77  European Parliament Committee on Industry, Research and Energy (ITRE), supra note 75. 
78  Regulation (EU) No 910/2014 of the European Parliament and of the Council of 23 July 2014 on electronic 
identification and trust services for electronic transactions in the internal market and repealing Directive 
1999/93/EC (OJ L 257 of 28.8.2014, p. 73). 
79  COM(2018) 233 final, 6. 
80  Gordon, Wright & Landman, supra note 5; SCHUMACHER, supra note 8, at 4. 
81  COMMISSION STAFF WORKING DOCUMENT, Accompanying the document Communication from the Com-
mission to the European Parliament, the Council, the European Economic and Social Committee and the 
Committee of the Regions on enabling the digital transformation of health and care in the Digital Single Mar-
ket; empowering citizens and building a healthier society, COM(2018) 233 final, SWD(2018) 126 final, 41. 
82  See COM(2018) 233 final, 7. 
